Try GOLD - Free

India plans strict rules for gene therapy

Mint Kolkata

|

October 24, 2025

India plans to bring the new generation of medical treatments involving gene and stem cell therapies under strict governmental control as the market for such treatments grows.

- Priyanka Sharma

India plans strict rules for gene therapy

The changes are aimed at amending the law to cover therapies like products derived from stem cells, gene therapy and xenografts

(AF)

The proposed changes are aimed at amending the law to cover therapies such as products derived from stem cells, gene therapy, and xenografts (animal-to-human transplants), according to documents reviewed by Mint.

This will bring manufacturing and licensing of these complex therapies under regulatory processes, ensuring the safety and quality of these cutting-edge biological products, two officials aware of the matter said as the draft is not public yet.

MORE STORIES FROM Mint Kolkata

Mint Kolkata

Mint Kolkata

With a $35 bn push, Amazon puts e-comm rivals on notice

Funds will support e-commerce, Amazon Web Services, Prime Video, MX Player and devices

time to read

2 mins

December 12, 2025

Mint Kolkata

US bombers join Japanese jets in show of force

The move follows Chinese and Russian drills in the skies and seas around Japan, South Korea

time to read

1 mins

December 12, 2025

Mint Kolkata

The kindness of strangers is one of the great rewards of running

How people often go out of their way to help is worth more than the health benefits that runners seek

time to read

3 mins

December 12, 2025

Mint Kolkata

Mint Kolkata

Jeff Bezos and Elon Musk race to bring data centers to space

Space companies backed by tech billionaires hope to move AI data centers off Earth

time to read

3 mins

December 12, 2025

Mint Kolkata

Volltamp rally now hinges on growth beyond peak margins

Shares of Voltamp Transformers

time to read

1 mins

December 12, 2025

Mint Kolkata

Mint Kolkata

Axis AMC to launch 3rd pvt credit fund

Fund house is looking to scale sharply in private-credit market

time to read

2 mins

December 12, 2025

Mint Kolkata

Novo moves Delhi HC on semaglutide

Danish drugmaker Novo Nordisk has moved Delhi high court's division bench seeking to restrain Dr. Reddy’s Laboratories from domestically manufacturing and exporting semaglutide—the blockbuster weight-loss and diabetes drug—to non-patent countries until its patent expires in March 2026.

time to read

1 min

December 12, 2025

Mint Kolkata

Bar on Prabhudas Lilladher stayed

The Securities Appellate Tribunal (SAT) has stayed an enquiry order issued by the Securities and Exchange Board of India (Sebi) that had barred Prabhudas Lilladher from taking on any new business for seven days over rule breaches.

time to read

1 min

December 12, 2025

Mint Kolkata

Mint Kolkata

HOMEOWNERSHIP 101: KEY COSTS BEYOND EMIs EVERY BUYER SHOULD BUDGET FOR

Owning a house is a dream for many.

time to read

3 mins

December 12, 2025

Mint Kolkata

Don't judge OMCs by their value

Oil marketing companies are likely to post strong earnings in FY26, given softer crude and unchanged retail prices.

time to read

2 mins

December 12, 2025

Listen

Translate

Share

-
+

Change font size